Refine
Has Fulltext
- yes (21)
Is part of the Bibliography
- yes (21)
Year of publication
Document Type
- Journal article (21)
Language
- English (21)
Keywords
- multiple myeloma (6)
- PET (5)
- positron emission tomography (5)
- medicine (3)
- molecular imaging (3)
- 18F-FDG PET/CT (2)
- CXCR4 (2)
- FDG (2)
- isotopes (2)
- radionuclide therapy (2)
- theranostics (2)
- 11C-Methionine PET/CT (1)
- 18FDG-PET/CT (1)
- 5IA-SPECT (1)
- 68Ga-DOTATATE (1)
- 68Ga-Pentixafor PET/CT (1)
- Antibodies (1)
- Atherosclerotic plaque (1)
- Carbon-11 (1)
- Cardiovascular risk factors (1)
- DOPA-responsive-dystonia (1)
- FDG-PET/CT (1)
- GCH1 (1)
- GPR54 (1)
- IBA-1 (1)
- KISS1 receptor (1)
- KISS1-54 (1)
- MRI (1)
- Macrophage (1)
- Matlab (1)
- Medizin (1)
- Multiple myeloma (1)
- Myeloma cells (1)
- Myelomas (1)
- PET/CT (1)
- PRRT (1)
- Parkinson disease (1)
- Parkinson's disease (1)
- Parkinson’s disease (1)
- Positron emission tomography (1)
- SAH (1)
- Somatostatin receptor (1)
- TBI (1)
- TSPO (1)
- [\(^{68}\)]KISS1-54 (1)
- \(^{11}\)C-Methionine-PET (1)
- \(^{11}\)C-methionine (1)
- \(^{18}\)F-FDG PET/CT (1)
- autoradiography (1)
- biosynthesis (1)
- bone disease (1)
- bone marrow cells (1)
- brain (1)
- cancer treatment (1)
- carboxylation (1)
- cell staining (1)
- cholinergic activity (1)
- cognitive decline (1)
- data analysis (1)
- diffuse (1)
- dopamine (1)
- dopamine acetylcholine (1)
- esophagogastric junction (1)
- exome sequencing (1)
- experience (1)
- focal (1)
- glioblastoma multiforme (1)
- glioma (1)
- health care (1)
- human tumor cell lines (1)
- imaging techniques (1)
- immunohistochemistry (1)
- immunostaining (1)
- isotopic labelling (1)
- kisspeptin (1)
- lesions (1)
- levodopa-induced dyskinesia (1)
- macrophages (1)
- magnetic resonance imaging (1)
- management (1)
- metabolic tumor volume (MTV) (1)
- metabolism (1)
- methionine (1)
- methylation (1)
- microglial cells (1)
- neuroinflammation (1)
- nicotinic receptors (1)
- pattern (1)
- peptide receptor (1)
- photons (1)
- preclinical imaging (1)
- progression (1)
- radiochemistry (1)
- radiogenomics (1)
- radiopharmaceuticals (1)
- relapse (1)
- sarcoidosis (1)
- signal to noise ratio (1)
- smoldering myeloma (1)
- somatostatin (1)
- somatostatin receptors (1)
- stem-cell transplantation (1)
- super ultraviolet (1)
- thyroid carcinomas (1)
- total lesion glycolysis (TLG) (1)
- total lesion methionine uptake (TLMU) (1)
- treatment response (1)
- weight drop (1)
Institute
- Klinik und Poliklinik für Nuklearmedizin (19)
- Medizinische Klinik und Poliklinik II (8)
- Neurologische Klinik und Poliklinik (4)
- Abteilung für Molekulare Innere Medizin (in der Medizinischen Klinik und Poliklinik II) (2)
- Institut für diagnostische und interventionelle Radiologie (Institut für Röntgendiagnostik) (2)
- Neurochirurgische Klinik und Poliklinik (2)
- Institut für Experimentelle Biomedizin (1)
- Institut für Klinische Epidemiologie und Biometrie (1)
- Institut für Klinische Transfusionsmedizin und Hämotherapie (1)
- Institut für Medizinische Strahlenkunde und Zellforschung (1)
Sonstige beteiligte Institutionen
EU-Project number / Contract (GA) number
- 680966 (1)
Kisspeptins (KPs, KISS1) and their receptor (KISS1R) play a pivotal role as metastasis suppressor for many cancers. Low or lost KP expression is associated with higher tumor grade, increased metastatic potential, and poor prognosis. Therefore, KP expression has prognostic relevance and correlates with invasiveness in cancers. Furthermore, KISS1R represents a very promising target for molecular imaging and therapy for KISS1R-expressing tumors. The goal of this study was to evaluate the developed KISS1-54 derivative, [\(^{68}\)Ga]KISS1-54, as a PET-imaging probe for KISS1R-expressing tumors. The NODAGA-KISS1-54 peptide was labeled by Gallium-68, and the stability of the resulting [\(^{68}\)Ga]KISS1-54 evaluated in injection solution and human serum, followed by an examination in different KISS1R-expressing tumor cell lines, including HepG2, HeLa, MDA-MB-231, MCF7, LNCap, SK-BR-3, and HCT116. Finally, [\(^{68}\)Ga]KISS1-54 was tested in LNCap- and MDA-MB-231-bearing mice, using µ-PET, assessing its potential as an imaging probe for PET. [\(^{68}\)Ga]KISS1-54 was obtained in a 77 ± 7% radiochemical yield and at a >99% purity. The [\(^{68}\)Ga]KISS1-54 cell uptake amounted to 0.6–4.4% per 100,000 cells. Moreover, the accumulation of [\(^{68}\)Ga]KISS1-54 was effectively inhibited by nonradioactive KISS1-54. In [\(^{68}\)Ga]KISS1-54-PET, KISS1R-positive LNCap-tumors were clearly visualized as compared to MDA-MB-231-tumor implant with predominantly intracellular KISS1R expression. Our first results suggest that [\(^{68}\)Ga]KISS1-54 is a promising candidate for a radiotracer for targeting KISS1R-expressing tumors via PET.